Eastern Asia: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Eastern Asia

In 2022, the East Asian medicaments containing corticosteroid hormones market increased by X% to $X for the first time since 2018, thus ending a three-year declining trend. In general, consumption recorded a pronounced contraction. Over the period under review, the market attained the peak level at $X in 2012; however, from 2013 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Corticosteroid Hormones in Eastern Asia

In value terms, medicaments containing corticosteroid hormones production declined to $X in 2022 estimated in export price. Overall, production, however, recorded a abrupt slump. The pace of growth appeared the most rapid in 2015 with an increase of X% against the previous year. The level of production peaked at $X in 2012; however, from 2013 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in Eastern Asia

For the third year in a row, Eastern Asia recorded growth in overseas shipments of medicaments containing corticosteroid hormones, which increased by X% to X tons in 2022. Total exports indicated resilient growth from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2018 indices. The most prominent rate of growth was recorded in 2017 when exports increased by X% against the previous year. The volume of export peaked in 2022 and is expected to retain growth in the near future.

In value terms, medicaments containing corticosteroid hormones exports surged to $X in 2022. Over the period under review, exports posted a remarkable increase. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

China prevails in exports structure, reaching X tons, which was approx. X% of total exports in 2022. Japan (X tons) held the second position in the ranking, followed by Hong Kong SAR (X tons). All these countries together took approx. X% share of total exports. South Korea (X tons) and Taiwan (Chinese) (X tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to medicaments containing corticosteroid hormones exports from China stood at X%. At the same time, Japan (X%), Taiwan (Chinese) (X%), South Korea (X%) and Hong Kong SAR (X%) displayed positive paces of growth. Moreover, Japan emerged as the fastest-growing exporter exported in Eastern Asia, with a CAGR of X% from 2012-2022. While the share of Japan (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, China ($X) emerged as the largest medicaments containing corticosteroid hormones supplier in Eastern Asia, comprising X% of total exports. The second position in the ranking was held by Japan ($X), with a X% share of total exports. It was followed by South Korea, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in China stood at X%. In the other countries, the average annual rates were as follows: Japan (X% per year) and South Korea (X% per year).

Export Prices by Country

In 2022, the export price in Eastern Asia amounted to $X per ton, increasing by X% against the previous year. Overall, the export price showed a relatively flat trend pattern. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Japan ($X per ton), while Taiwan (Chinese) ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the other leaders experienced a decline in the export price figures.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in Eastern Asia

Medicaments containing corticosteroid hormones imports reached X tons in 2022, picking up by X% on the previous year. Total imports indicated a buoyant expansion from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2012 indices. The most prominent rate of growth was recorded in 2016 when imports increased by X%. The volume of import peaked in 2022 and is likely to see gradual growth in years to come.

In value terms, medicaments containing corticosteroid hormones imports totaled $X in 2022. Total imports indicated a resilient increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2012 indices. The pace of growth was the most pronounced in 2014 when imports increased by X%. The level of import peaked in 2022 and is expected to retain growth in the near future.

Imports by Country

In 2022, China (X tons) represented the major importer of medicaments containing corticosteroid hormones, making up X% of total imports. Japan (X tons) held a X% share (based on physical terms) of total imports, which put it in second place, followed by South Korea (X%). Taiwan (Chinese) (X tons) held a minor share of total imports.

Imports into China increased at an average annual rate of X% from 2012 to 2022. At the same time, Taiwan (Chinese) (X%), South Korea (X%) and Japan (X%) displayed positive paces of growth. Moreover, Taiwan (Chinese) emerged as the fastest-growing importer imported in Eastern Asia, with a CAGR of X% from 2012-2022. From 2012 to 2022, the share of China increased by X percentage points. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest medicaments containing corticosteroid hormones importing markets in Eastern Asia were China ($X), Japan ($X) and South Korea ($X), together accounting for X% of total imports. Taiwan (Chinese) lagged somewhat behind, comprising a further X%.

Taiwan (Chinese), with a CAGR of X%, recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Eastern Asia amounted to $X per ton, picking up by X% against the previous year. Over the period under review, the import price, however, showed a relatively flat trend pattern. The growth pace was the most rapid in 2017 when the import price increased by X%. The level of import peaked at $X per ton in 2014; however, from 2015 to 2022, import prices stood at a somewhat lower figure.

Average prices varied noticeably amongst the major importing countries. In 2022, major importing countries recorded the following prices: in Japan ($X per ton) and China ($X per ton), while South Korea ($X per ton) and Taiwan (Chinese) ($X per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Taiwan (Chinese) (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :